Apple Display Technology Leaves Investors with Sour Taste (Reuters)
Apple Inc.(AAPL) investors had been anxiously awaiting the rollout of the next generation iPad Mini with “retina” display. This latest high resolution, image technology was supposed to put the Cupertino, Calif.-based company back on par with Google and Amazon tablets, and hopefully sweeten the company’s incredibly sour share price. Well, those investors need to be patient, as Apple’s supply chain is only now gearing up to produce the next gen screens. Worst of all, retina technology isn’t expected to be available during the critical holiday shopping season. Apple investors better start thinking about New Year’s resolutions.
Like This Article? Now Get Mark's FREE Special Report: 3 Dividend Plays with Sky-High Returns
This newly-released report by a top-20 living economist details three investments that are your best bets for income and appreciation for the rest of the year and beyond.
Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:
Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.
Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:
Jon Johnson's philosophy in investing and trading is to take what the market gives you regardless if that is to the upside or downside. For the past 21 years, Jon has helped thousands of clients gain success in the financial markets through his newsletters and education services:
Get free access to "Millionaire Maker" Hilary Kramer's latest report 3 Biotech Breakthroughs To Bank On. Simply tell us where to send it in the box below.
*Along with my FREE report, Hilary Kramer's
3 Biotech Breakthroughs to Bank On, please also send Hilary's free weekly e-letter, Trading Desk. We value your privacy. You will not be spammed, ever. Period.